GSTM3 reverses the resistance of hepatoma cells to radiation by regulating the expression of cell cycle/apoptosis-related molecules

Oncology Letters

Volumn 8, Issue 4, 2014, Pages 1435-1440

  Sun, Ying ^a   Wang, Yu ^b   Yin, Yufeng ^b   Chen, Xianghua ^c   Sun, Zhijun ^a  

^a SHANDONG MEDICAL COLLEGE   (China)

^b PEOPLE S HOSPITAL OF RIZHAO   (China)

^c The Health Department of Shandong Province   (China)

Author keywords

Apoptosis; Cell cylce arrest; GSTM3; Hepatocellular carcinoma; Radioresistance

Indexed keywords

GLUTATHIONE TRANSFERASE M3; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P27; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL PROLIFERATION ASSAY; CELL VIABILITY; CLONOGENIC ASSAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE POLYMERASE CHAIN REACTION; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; WESTERN BLOTTING;

EID: 84923068153     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2358     Document Type: Article

References (24)

1. El-Serag HB: Hepatocellular carcinoma. N Engl J Med 365: 1118-1127, 2011.
2. Kim JJ and Tannock IF: Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer 5: 516-525, 2005.
3. Leveille-Webster CR and Arias IA: Establishment and serial quantification of intrahepatic xenografts of human hepatocellular carcinoma in severe combined immunodeficiency mice, and development of therapeutic strategies to overcome multidrug resistance. Clin Cancer Res 2: 695-706, 1996.
4. Ryoo K, Huh SH, Lee YH, et al: Negative regulation of MEKK1-induced signaling by glutathione S-transferase Mu. J Biol Chem 279: 43589-43594, 2004.
5. Lu M, Xia L, Luo D, Waxman S and Jing Y: Dual effects of glutathione-S-transferase pi on As 2O3 action in prostate cancer cells: enhancement of growth inhibition and inhibition of apoptosis. Oncogene 23: 3945-3952, 2004.
6. Adler V, Yin Z, Fuchs SY, et al: Regulation of JNK signaling by GSTp. EMBO J 18: 1321-1334, 1999.
7. Yin Z, Ivanov VN, Habelhah H, Tew K and Ronai Z: Glutathione S-transferase p elicits protection against H 2O2-induced cell death via coordinated regulation of stress kinases. Cancer Res 60: 4053-4057, 2000.
8. Yu KD, Fan L, Di GH, et al: Genetic variants in GSTM3 gene within GSTM4-GSTM2-GSTM1-GSTM5-GSTM3 cluster influence breast cancer susceptibility depending on GSTM1. Breast Cancer Res Treat 121: 485-496, 2010.
9. Tan X, Zhai Y, Chang W, et al: Global analysis of metastasis-associated gene expression in primary cultures from clinical specimens of clear-cell renal-cell carcinoma. Int J Cancer 123: 1080-1088, 2008.
10. Smith L, Welham KJ, Watson MB, et al: The proteomic analysis of cisplatin resistance in breast cancer cells. Oncol Res 16: 497-506, 2007.
11. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2 {replacement character}ΔΔCt method. Methods 25: 402-408, 2001.
12. Chen YJ, Lin CP, Hsu ML, et al: Sonic hedgehog signaling protects human hepatocellular carcinoma cells against ionizing radiation in an autocrine manner. Int J Radiat Oncol Biol Phys 80: 851-859, 2011.
13. Urick ME, Chung EJ, Shield WP III, et al: Enhancement of 5-fluorouracil-induced in vitro and in vivo radiosensitization with MEK inhibition. Clin Cancer Res 17: 5038-5047, 2011.
14. Piao LS, Hur W, Kim TK, et al: CD133 + liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma. Cancer Lett 315: 129-137, 2012.
15. Mannervik B, Awasthi YC, Board PG, et al: Nomenclature for human glutathione transferases. Biochem J 282: 305-306, 1992.
16. Salinas-Souza C, Petrilli AS and de Toledo SR: Glutathione S-transferase polymorphisms in osteosarcoma patients. Pharmacogenet Genomics 20: 507-515, 2010.
17. Chatzimichalis M, Xenellis J, Tzagaroulakis A, et al: GSTT1, GSTM1, GSTM3 and NAT2 polymorphisms in laryngeal squamous cell carcinoma in a Greek population. J Laryngol Otol 124: 318-323, 2010.
18. Golka K, Schmidt T, Seidel T, et al: The influence of polymorphisms of glutathione S-transferases M1 and M3 on the development of human urothelial cancer. J Toxicol Environ Health A 71: 881-886, 2008.
19. Jain M, Kumar S, Lal P, et al: Role of GSTM3 polymorphism in the risk of developing esophageal cancer. Cancer Epidemiol Biomarkers Prev 16: 178-181, 2007.
20. Hao YX, Zhong H, Yu PW, et al: Effects of HIF-1alpha on human gastric cancer cell apoptosis at different CO(2) pressures. Clin Exp Med 9: 139-147, 2009.
21. Liu F, Wei YG, Luo LM, et al: Genetic variants of p21 and p27 and hepatocellular cancer risk in a Chinese han population: a case-control study. Int J Cancer 132: 2056-2064, 2013.
22. Lamore SD and Wondrak GT: Zinc pyrithione impairs zinc homeostasis and upregulates stress response gene expression in reconstructed human epidermis. Biometals 24: 875-890, 2011.
23. Cabello CM, Lamore SD, Bair WB III, et al: DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO1 * 2 breast carcinoma. Free Radic Res 45: 276-292, 2011.
24. He HB, Wu XL, Yu B, et al: The effect of desacetyluvaricin on the expression of TLR4 and P53 protein in Hepg 2.2.15. Hepat Mon 11: 364-367, 2011.